StonvexLoading…
StonvexStonvexStonvexCore line items from KC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.37B | $1.07B | $992.61M | $1.19B |
Operating Income | $-110.53M | $-238.24M | $-296.98M | $-326.42M |
Net Income | $-133.88M | $-269.43M | $-306.53M | $-385.40M |
EPS (Diluted) | $-0.03 | $-0.07 | $-0.09 | $-0.11 |
Total Assets | $3.82B | $2.41B | $2.12B | $2.51B |
Total Liabilities | $2.49B | $1.66B | $1.10B | $1.12B |
Cash & Equivalents | $860.57M | $362.88M | $317.65M | $495.73M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 3.69B | 4.48B | 3.56B | 3.51B |